Vijaya Diagnostic Centre Ltd. · NSE:VIJAYA
Vijaya Diagnostic Centre — Q1 FY25 Earnings Presentation
48 slides from Vijaya Diagnostic Centre's earnings presentation, Aug 5, 2024
Slide 1: Exchange intimation letter for investor presentation
August 05, 2024 To, To, Listing Department The Corporate Relations Department National Stock Exchange Of India Limited, BSE Limited, Exchange Plaza, Phiroz Jeejeebhoy Towers, Bandra Kurla Complex, 25th floor, Dalal Street, Bandra (East), Mumbai- 400 051 Mumbai - 400 001 NSE Symbol. VIJAYA BSE Scrip
Slide 2: Q1 FY25 Earnings Presentation, August 05 2024
Q1 FY25 Earnings Presentation, August 05 2024
Slide 3: Safe Harbour
Safe Harbour This presentation and the accompanying slides (the “Presentation”), which have been prepared by Vijaya Diagnostic Centre Limited (the ‘Company’), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for
Slide 4: Disclaimer
Disclaimer Note 1: Disclaimer Acquisition (PH Diagnostic Centre Private Limited, Pune) : PH has become a whole owned subsidiary effective from 21st December 2023. Consequently, its financials have been consolidated from 21st December 2023 in the last financial year FY 2023-24. Hence, the consolidate
Slide 5: Q1 FY25 – Performance Snapshot
Q1 FY25 – Performance Snapshot Q1 FY25 Q1 FY24 YoY % Q4 FY24 QoQ % Revenue 1,562 1,210 29.1% 1,552 0.7% GR % Revenue Excl. PH 1,448 1,210 19.6% 1,434 1.0% EBIDTA 612 481 27.3% 631 -3.0% EBIDTA Margin 39.2% 39.8% -60 BPs 40.7% -150 BPs Total tests 3.38 2.62 28.7% 3.36 0.5% Total Footfall 0.96 0.79 22
Slide 6: Q1 FY25 – Performance Snapshot
Q1 FY25 – Performance Snapshot Operational & Financial Highlights – Q1 FY25 3.38 Mn Tests 0.96 Mn INR 1,562 Mn INR 1,448 Mn 19.6% 19.8% 16.6% Footfalls Revenue from Revenue from Revenue Test Volume Footfall growth (YoY) growth (YoY) growth (YoY) operations Operations Excluding PH 146 Centres (Includ
Slide 7: Management comment
Management comment Commenting on the Q1FY25 results performance, Ms. Suprita Reddy, MD & CEO at Vijaya Diagnostic Centre Ltd. said: “I'm happy to announce another strong quarter, highlighted by a remarkable year-on-year revenue growth of 29.1%, with an impressive 19.6% achieved organically. This gro
Slide 8: Key Financial Highlights – Q1 FY25
Key Financial Highlights – Q1 FY25 Revenue from Operations EBITDA & EBITDA Margin (%) 39.8% 40.7% 39.2% 39.6% 40.3% 2,209 5,478 1,820 4,592 1,552 1,562 481 631 612 1,210 Q1 FY24 Q4 FY24 Q1 FY25 FY23 FY24 Q1 FY24 Q4 FY24 Q1 FY25 FY23 FY24 Shift YoY (%) 29.1% 19.3% 27.3% 21.4% PAT & PAT Margin (%) 21.
Slide 9: Revenue Mix – Q1 FY25
Revenue Mix – Q1 FY25 Radiology vs. Pathology Breakdown Wellness share % Radiology Pathology 12.4% 13.9% 13.4% 12.1% 12.9% 63% 63% 62% 65% 64% 37% 37% 38% 35% 36% Q1 FY24 Q4 FY24 Q1 FY25 FY23 FY24 Q1 FY24 Q4 FY24 Q1 FY25 FY23 FY24 B2C Contribution – Q1 FY25 B2B 7% B2C 93% 8 (IN %)
Slide 10: Q1 FY25 – Key Developments
Q1 FY25 – Key Developments Achieved operational break-even within just 3 quarters in Kolkata, West Bengal • Launched one-of-a-kind hub in Kolkata, West Bengal in July 2023. Kolkata, West Bengal • This 10,000 sq ft facility has an automated lab, houses advanced equipment such as a 3T MRI & 128 slice
Slide 11: Geographical Contribution - Revenue
Geographical Contribution - Revenue 83% 78% 71% 72% 18% 17% 17% 14% 7% 8% 2% 3% 3% 3% 2% 0% Hyderabad RoAPT Pune Kolkata Q1 FY25 Q4 FY24 FY24 FY23 Centre count as on 30.06.2024 Hyderabad RoAPT Pune Kolkata Others Total 93 31 18 2 2 146 10
Slide 12: Key Operational Highlights
Key Operational Highlights Tests Performed (# in Million) Footfalls (# in Million) Tests / Footfalls (# in Million) 3.55 3.51 11.89 3.18 3.44 10.05 3.34 3.35 3.38 0.98 0.96 3.17 2.62 3.36 0.79 Q1 FY24 Q4 FY24 Q1 FY25 FY23 FY24 Q1 FY24 Q4 FY24 Q1 FY25 FY23 FY24 Q1 FY24 Q4 FY24 Q1 FY25 FY23 FY24 Reven
Slide 13: Consolidated Profit & Loss Account
Consolidated Profit & Loss Account Particulars Q1 FY25 Q1 FY24 YoY Q4 FY24 QoQ Revenue from operations 1,562.2 1,210.5 29.1% 1,552.1 0.7% Cost of materials consumed 187.6 142.9 31.3% 188.1 -0.3% Employee benefits expense 273.6 208.5 31.2% 245.2 11.6% Other expenses 488.6 377.9 29.3% 487.6 0.2% EBITD
Slide 14: Beyond Organic for Exponential Reach
BEYOND ORGANIC FOR EXPONENTIAL REACH
Slide 15: About PH – company background
About this company Disclaimer Established in 2001, PH is Pune’s largest B2C focused Integrated Diagnostic Chain. Being in the space for 23 long years, it has emerged as a brand of choice, enjoying the trust and patronage of customers across the region. The founder, Dr. Hemanth Dhoka, a Doctor by pro
Slide 16: High Quality Infrastructure
High Quality Infrastructure 15
Slide 17: Superior Facilities
ge. Superior Facilities VIJAYA ne; DIAGNOSTIC [WisavA] CENTRE The Pioneers in Diagnostic Medicare... 16
Slide 18: Key Highlights
Key Highlights Type of Facility Services Available Count Hubs Sample collection, Ultrasound, X-Ray, 2D Echo, BMD, 3 MRI, CT etc., Spokes Sample collection, Ultrasound, X-Ray, 2D Echo etc., 3 Collection Centres (Company run) Sample collection only 12 Total customer facing centres 18 Processing Labora
Slide 19: State-of-the-art Medical Equipment
State-of-the-art Medical Equipment 18
Slide 20: Vijaya PH Diagnostic Centre rebrand
Building a Stronger Future: Introducing Vijaya PH Diagnostic Centre Disclaimer is now 19
Slide 21: Building a Stronger Future: Introducing Vijaya PH Diagnostic Centre
Building a Stronger Future: Introducing Vijaya PH Diagnostic Centre 20
Slide 22: Strategic Expansion
VIJAYA DIAGNOSTIC CENTRE Strategic Expansion
Slide 23: Expanding Strategically in alignment with our vision
Expanding Strategically in alignment with our vision Inorganic Expansion Strategy • Successfully acquired PH, Pune's largest B2C integrated diagnostic chain, expanding our reach. East India Strategy • This strategic acquisition seamlessly aligns with our commitment to providing top-notch • With grow
Slide 24: Company Overview
VIJAYA DIAGNOSTIC CENTRE Company Overview
Slide 25: Vijaya at a Glance
Vijaya at a Glance Vijaya Diagnostic Centre Limited is the largest integrated diagnostic chain in South India with 146 state-of-the-art centres spread across 23 cities 40+ 146 Mission Years of Experience Centres Quality Experience in delivering Quality Our Mission is to make the patient’s medical Di
Slide 26: Our Journey
Our Journey Awarded one of the Best Healthcare Brands 2022 by The Economic Times Awarded Brand of the year One of the earliest in diagnostic services by The Won the Healthcare Leadership Acquired 100% private diagnostic Vijaya Diagnostic Centre Recognized as one of the CEO Magazine and Awards 2022 s
Slide 27: At the Forefront of Introducing New Technologies
At the Forefront of Introducing New Technologies Ultrasound & Nuclear Medicine Fourth Generation 1981 Echocardiography 1986 1993 CT Scan 1994 Mammography facility Hawkeye Gamma Automated Microbiology Real Time RT-PCR Assays 2006 2003 Culture 2000 1999 Bone Densitometry Camera with SPECT & Flow Cytom
Slide 28: Our Pillars of Strength
Our Pillars of Strength 1 One of the leading players in India’s high growth diagnostics market 2 Integrated diagnostics provider offering one-stop solution 3 High brand recall driving customer stickiness 4 Robust technical capabilities and state-of-the-art technology 5 Experienced Board and strong m
Slide 29: One-Stop Solutions for Pathology & Radiology
…offering One-Stop Solutions for Pathology & Radiology Complete Range of Diagnostic Services under One Roof Comprehensive and high-quality integrated diagnostic services through our operational network 28
Slide 30: Robust Technical Capabilities with State-of-the-art IT Infrastructure
Robust Technical Capabilities with State-of-the-art IT Infrastructure 31 8 Advanced Software to Manage Clinical Data CT Machines PET CT / Gamma machines 29 250+ MRI Machines Fully Integrated Radiology Radiologists, Lab Doctors & Advance Laboratory Information Systems (RIS) and Physicians Information
Slide 31: Awards & Achievements
Awards & Achievements Vijaya Diagnostic Centre has been recognized with Vijaya Diagnostic Centre has been awarded Vijaya Diagnostic Centre has been recognized as with “Best Healthcare Brands 2024” by ET “Most trusted brand of India“ by Marksmen Daily “Most trusted brand of the Year Award“ Edge at 4t
Slide 32: Awards & Achievements
Awards & Achievements Our consultant radiologist, Dr. Varsha Joshi, has Vijaya Diagnostic Centre was awarded made significant contributions as an Associate Vijaya Diagnostic Centre has been Editor to the recently published 8th Edition of for excellence in comprehensive recognized for service excelle
Slide 33: Doctors connect program
Doctors connect program Vijaya Diagnostic Centre has organized a Vijaya Diagnostic Centre has organized a Vijaya Diagnostic Centre has organized a continuing medical education (CME) on continuing medical education (CME) on continuing medical education (CME) on Urology in association with NAUS in Viz
Slide 34: Doctors connect program
Doctors connect program Vijaya Diagnostic Centre has organized Vijaya Diagnostic Centre has organized Vijaya Diagnostic Centre has organized a continuing medical education (CME) a continuing medical education (CME) a continuing medical education (CME) on Orthopedics in association with webinar on “C
Slide 35: Experienced Board of Directors
Experienced Board of Directors Dr. S Surendranath Reddy – Founder and Executive Chairman Dr. D Nageshwar Reddy - Non-executive, Independent Director ▪ Founder of Vijaya with 40+ years of experience in building Vijaya as South India’s largest integrated diagnostic chain ▪ Chairman of Asian Institute
Slide 36: Strong Management Team
Strong Management Team Dr. S. Surendranath Reddy Ms. Suprita Reddy Mr. Sunil Chandra Kondapally Mr. Narasimha Raju K.A Founder and Executive Managing Director and Chief Executive Director Chief Financial Officer Chairman Executive Officer Mr. Sheshadri Vasan Mr. Sivaramaraju Vegesna Mr. Hansraj Sing
Slide 37: Awards & Accolades
Awards & Accolades Most Trusted Brand of the Excellence In Comprehensive Excellence In Comprehensive Best Healthcare Brands Best Healthcare Brands’2024 Most Trusted Brand of India Year Diagnostic Care Diagnostic Care 2024 - 25 Presented by Recognized 22nd Global by ET Edge for Brought to Times Healt
Slide 38: Shareholding Pattern as of 30th June 2024
Shareholding Pattern as of 30th June 2024 Shareholding Pattern – As of 30th June, 2024 Retail & Others Total 4% Marquee Institutional Investors Wasatch Nippon India Aberdeen Institutional Promoter & Mirae Holding Promoter Group 42% Total Axis 54% Kotak DII’s: Mutual Funds, AIF’s and QIB’s Others: Re
Slide 39: Financial & Operational Highlights
Financial & Operational Highlights
Slide 40: Disclaimer
Disclaimer Note 2: Disclaimer "With effect from 01 January 2023, the Company has changed its method of depreciation on all Property, Plant and Equipment from Written Down Value (“WDV") method to Straight Line Method (“SLM"), based upon the technical assessment of expected pattern of consumption of t
Slide 41: Robust Operational Metrics
Robust Operational Metrics Diagnostic Centre (Nos) Footfalls (Mn) Tests Performed (Mn) 3.62 3.55 11.89 3.18 145 2.79 10.05 2.63 9.32 121 7.91 95 7.09 73 80 FY20 FY21 FY22 FY23 FY 24 FY20 FY21 FY22 FY23 FY 24 FY20 FY21 FY22 FY23 FY 24 Test per Footfall (Nos) Revenue per Test (INR) Revenue per Footfal
Slide 42: Consistent Financial Performance
Consistent Financial Performance Revenue EBIDTA PAT CAGR:12.8% CAGR:13.6% CAGR:17.4% 5,478 2,209 4,624 4,592 2,037 1,188 1,660 1,820 1,097 3,388 3,767 845 846 1,326 625 FY20 FY21 FY22 FY23 FY24 FY20 FY21 FY22 FY23 FY24 FY20 FY21 FY22 FY23 FY24 EBIDTA Margin (%) PAT Margin (%) 120 bps 320 bps 22.4% 2
Slide 43: Sustainable Cash Generation & Increasing Return Ratios
Sustainable Cash Generation & Increasing Return Ratios Cash & Cash Equivalents CFO / EBIDTA (%) (INR Mn) 2,466 2,554 90% 2,277 1,729 1,822 83% 80% 78% 77% FY20 FY21 FY22 FY23 FY 24 FY20 FY21 FY22 FY23 FY 24 RoCE Pre-Cash (%) RoE 1 (%) 23% 23% 23% 43% 38% 18% 33% 16% 25% 23% FY20 FY21 FY22 FY23 FY 24
Slide 44: Annexure
VIJAYA & DIAGNOSTIC [WIJAYA | CENTRE Annexure
Slide 45: Consolidated Profit & Loss Account
Consolidated Profit & Loss Account Particulars FY24 FY23 FY22 FY21 FY20 Revenue from operations 5,478 4,592 4,624 3,767 3,388 Cost of materials consumed 654 589 715 571 439 Employee benefits expense 902 785 707 574 624 Other expenses 1,712 1,398 1,165 962 999 EBITDA 2,209 1,820 2,037 1,660 1,326 EBI
Slide 46: Consolidated Balance Sheet
Consolidated Balance Sheet Assets Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 EQUITY AND LIABILITIES Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 NON-CURRENT ASSETS 7,714 5,777 4,436 3,022 2,959 EQUITY 6,599 5,466 4,695 3,592 2,741 Property, plant and equipment 3,785 2,940 1,966 1,358 1,398 Equity share capital 102 10
Slide 47: Consolidated Cash Flow Statement
Consolidated Cash Flow Statement Particulars Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Cash Flow from Operating Activities Profit before Tax 1,587 1,135 1,474 1,121 834 Adjustment for Non-Operating Items 599 683 572 534 492 Operating Profit before Working Capital Changes 2,186 1,818 2,046 1,655 1,326 Chang
Slide 48: Thank You
Thank You For further information please contact: Mr. Siva Rama Raju Head – Strategy & Investor Relations +91 99485 95555 sivaramaraju.v@vijayadiagnostic.in ir@vijayadiagnostic.in www.vijayadiagnostic.com Corporate Office : #6-3-883/F, FPA Building, Near Topaz Building, Punjagutta, Hyderabad-500082,
Vijaya Diagnostic Centre — Q1 FY25 Earnings Presentation on 6ix